Albumin binding to SPARC expressed in tumor tissue has also been implicated in increased accumulation of albumin-binding therapeutics,27 and we found that SPARC is expressed in both EMT6 and B16.F10 tumors (Fig. S11) and may therefore contribute to nAlb accumulation. Here, ALB is linked to neoplasm.